These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6502234)

  • 1. Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma.
    Levin VA; Edwards MS; Gutin PH; Vestnys P; Fulton D; Seager M; Wilson CB
    J Neurosurg; 1984 Dec; 61(6):1063-8. PubMed ID: 6502234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
    Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
    Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of primary brain tumors.
    Levin VA
    Neurol Clin; 1985 Nov; 3(4):855-66. PubMed ID: 3001491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study.
    Ragab AH; Burger P; Badnitsky S; Krischer J; Van Eys J
    J Neurooncol; 1986; 3(4):341-2. PubMed ID: 3958779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
    Gaynon PS; Ettinger LJ; Baum ES; Siegel SE; Krailo MD; Hammond GD
    Cancer; 1990 Dec; 66(12):2465-9. PubMed ID: 2249186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
    Hurwitz CA; Strauss LC; Kepner J; Kretschmar C; Harris MB; Friedman H; Kun L; Kadota R
    J Pediatr Hematol Oncol; 2001; 23(5):277-81. PubMed ID: 11464982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of recurrent pediatric posterior fossa tumors.
    Edwards MS; Levin VA; Wilson CB
    Clin Neurosurg; 1983; 30():209-25. PubMed ID: 6667576
    [No Abstract]   [Full Text] [Related]  

  • 9. A phase II evaluation of thiotepa in pediatric central nervous system malignancies.
    Heideman RL; Packer RJ; Reaman GH; Allen JC; Lange B; Horowitz ME; Steinberg SM; Gillespie A; Kovnar EH; Balis FM
    Cancer; 1993 Jul; 72(1):271-5. PubMed ID: 8508417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
    Corden BJ; Strauss LC; Killmond T; Carson BS; Wharam MD; Kumar AJ; Piantadosi S; Robb PA; Phillips PC
    J Neurooncol; 1991 Aug; 11(1):57-63. PubMed ID: 1919647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms.
    Sklansky BD; Mann-Kaplan RS; Reynolds AF; Rosenblum ML; Walker MD
    Cancer; 1974 Feb; 33(2):460-7. PubMed ID: 4812764
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group.
    Bertolone SJ; Baum ES; Krivit W; Hammond GD
    J Neurooncol; 1989 May; 7(1):5-11. PubMed ID: 2754456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
    Hauser P; Vancsó I; Pócza T; Schuler D; Garami M
    Magy Onkol; 2013 Dec; 57(4):259-63. PubMed ID: 24353991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin in the treatment of recurrent childhood primary brain tumors.
    Walker RW; Allen JC
    J Clin Oncol; 1988 Jan; 6(1):62-6. PubMed ID: 2826716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study.
    Sexauer CL; Khan A; Burger PC; Krischer JP; van Eys J; Vats T; Ragab AH
    Cancer; 1985 Oct; 56(7):1497-501. PubMed ID: 4040799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of chemotherapy for malignant brain tumors].
    Takeshima H; Kuratsu J
    No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.
    Fouladi M; Nicholson HS; Zhou T; Laningham F; Helton KJ; Holmes E; Cohen K; Speights RA; Wright J; Pollack IF;
    Cancer; 2007 Dec; 110(11):2535-41. PubMed ID: 17932894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain tumors.
    Ashby LS; Obbens EA; Shapiro WR
    Cancer Chemother Biol Response Modif; 1999; 18():498-549. PubMed ID: 10800500
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of malignant scala posterior tumors in children: II. Preliminary result of the pre- and postoperative adjuvant chemotherapy of scala posterior tumors.
    Schuler D; Somló P; Koós R; Kálmánchey R; Paraicz E
    Med Pediatr Oncol; 1993; 21(4):274-9. PubMed ID: 8469223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study.
    Vasantha Kumar AR; Renaudin J; Wilson CB; Boldrey EB; Enot KJ; Levin VA
    J Neurosurg; 1974 Mar; 40(3):365-71. PubMed ID: 4360491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.